Good quarterly update. The science model progressing nicely. Imminent commencement of the Ptx-100 trial (s), awaiting collaboration results/finding and current concurrent three trials of the Ptx-200 as scheduled. The business model on funding is nearing review (IMO). That is, current funds at 4.2 mil (including tax rebate), yet next quarter estimated at a burn rate of 2.2mil. Obviously a plausible explanation as to the recent sell down we are/ have witnessed. So, interesting two quarters re CR requirements... , let’s hope timing, past mistakes, dilution and holder value ( not just majors) are on the boards and ceo’s Priorities. GLTAH
PTX Price at posting:
7.0¢ Sentiment: Buy Disclosure: Held
